| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065213 Increasing the duration of expression of a delivered gene in target cells by delivering a gene encoding a cellular retention activity and nuclear binding sequence to target cells before or during gene of interest delivery |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064887 Apparatus for use in the deposition of substrate on solid support |
| 05/30/2002 | US20020064879 Method for obtaining a plant with a genetic lesion in a gene sequence |
| 05/30/2002 | US20020064878 Nucleotide sequences for use as tools in genetic engineering |
| 05/30/2002 | US20020064876 Genetically engineering cells of skin; obtain cells, transform with expression vector, monitor cells for preferential phenotypes |
| 05/30/2002 | US20020064871 Endogenous ketogulonigenium plasmid |
| 05/30/2002 | US20020064870 Replication defective microorganismal vectors for use in the treatment of vision defects |
| 05/30/2002 | US20020064869 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064858 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064854 Enzymatic polypeptide for use in detergents for automatic dishwashers and laundry detergents |
| 05/30/2002 | US20020064853 Nucleotide sequences coding enzymatic polypeptide for use in treatment of cancer, nervous system, cardiovascular and inflammatory disorders, restenosis and arteriosclerosis |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064850 Nucleotide sequences for use in generating fructose polymers for food processing |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064847 Polypeptide for use generation of preferential compounds |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064834 Microbiological production method for alpha-L-aspartyl-L-phenylalanine |
| 05/30/2002 | US20020064833 Nucleotide sequences for use in the treatment of drug abuse and drug dependence |
| 05/30/2002 | US20020064831 Nucleotide sequences coding polypeptides associated capillary morphogenesis; for use in controlling neovascularization; antitumor agents |
| 05/30/2002 | US20020064830 Nucleotide sequences for use as diagnostic tools |
| 05/30/2002 | US20020064829 Human tumor necrosis factor delta and epsilon |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064824 Generating preferential binding protein; obtain nucleotide sequences, replace preferential nucleotides, translate nucleotide sequences, recover preferential protein |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064816 Nuclelotide sequences coding polysaccharide metabolism protein for use in generating transgenic plants |
| 05/30/2002 | US20020064813 Nucleotide sequences for use in the treatment of infections, pain; cancers; diabetes, eating, psychological, urogenital and neurological disorders; hypotension; hypertension; osteoporosis; angina pectoris; stroke; ulcers; allergies |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064811 Dna encoding the human synapsin iii gene and uses thereof |
| 05/30/2002 | US20020064802 Associating protein with chromosomes; monitor chromosome, detect target association position, transform cell, detect proteins association with chromosome |
| 05/30/2002 | US20020064798 Combinatorial enzymatic complexes |
| 05/30/2002 | US20020064793 Screen for compounds with affinity for nucleic acids |
| 05/30/2002 | US20020064790 Generating nucleotide sequence binding ligand; obtain ligandthat binds to nucleotide sequence, monitor binding activity of particle and sequences, recover ligands that utilizes reduced energy to bind sequences compare to wild type |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064784 Monitoring drug binding activity; obtain cells, generate mutation in cell genome, detect killing mutation, recover protein generated |
| 05/30/2002 | US20020064783 Inhibition of bone tumor formation using antisense cDNA therapy |
| 05/30/2002 | US20020064782 Fluorescent nucleotides |
| 05/30/2002 | US20020064780 Detecting preferential nucleic acids; incubate target nucleic acids and ligands, separate bound particles, amplify nucleotide sequences, detect ligand |
| 05/30/2002 | US20020064777 Recombination repair gene, MIM, from arabidopsis thaliana |
| 05/30/2002 | US20020064539 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
| 05/30/2002 | US20020064532 Virus mutant of given nucleotide sequence; vaccine can be administered to poultry by mass application routes |
| 05/30/2002 | US20020064530 Variants of phleum pratense allergenic proteins |
| 05/30/2002 | US20020064527 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064520 Targeted artificial gene delivery |
| 05/30/2002 | US20020064517 Applying a fibrin gel to the cell to be transformed to entrap a nucleic acid being used, transforming the cell; gene therapy; kits |
| 05/30/2002 | US20020062835 Methods of modulating hair growth |
| 05/30/2002 | CA2439184A1 Aspergillus fumigatus cofilin |
| 05/30/2002 | CA2439164A1 Aspergillus fumigatus profilin |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/30/2002 | CA2430275A1 Human v2 vomeronasal receptor |
| 05/30/2002 | CA2430270A1 Methods and materials for the synthesis of organic products |
| 05/30/2002 | CA2429971A1 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
| 05/30/2002 | CA2429860A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | CA2429633A1 Method for analyzing mass spectra |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | CA2429467A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | CA2429368A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | CA2429039A1 3-hydroxypropionic acid and other organic compounds |
| 05/30/2002 | CA2428979A1 Human erg2 potassium channel |
| 05/30/2002 | CA2428885A1 Method of separating extra-chromosomal dna from other cellular components |
| 05/30/2002 | CA2427886A1 Method for detecting protozoae of the genus naegleria |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
| 05/30/2002 | CA2426477A1 Compositions, methods and kits relating to remodelin |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/30/2002 | CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/29/2002 | EP1209612A2 Methods and computer software products for predicting nucleic acid hybridization affinity |
| 05/29/2002 | EP1209242A2 Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus (SRSV) |
| 05/29/2002 | EP1209241A2 Gene expression analysis |
| 05/29/2002 | EP1209237A2 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 05/29/2002 | EP1209236A1 phosphomevalonate kinases from plants |
| 05/29/2002 | EP1209235A1 Expression vector for fusion gene and method for producing immobilized enzyme |
| 05/29/2002 | EP1209234A1 Stereostructure of decarbamylase and method of using the same |
| 05/29/2002 | EP1209233A2 Alkaline proteases |
| 05/29/2002 | EP1209232A1 Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
| 05/29/2002 | EP1209231A1 Meg-1 protein |
| 05/29/2002 | EP1209230A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 05/29/2002 | EP1209229A1 Gene involved in schizophrenia |
| 05/29/2002 | EP1209228A2 Environmental stress responsive promoter |
| 05/29/2002 | EP1209227A2 Cytochrome P450 hydroxylase, an important enzyme in brassinosteroid biosynthesis of plants |
| 05/29/2002 | EP1209168A1 Polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208909A2 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |